Trials / Completed
CompletedNCT00272558
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
Phase II Study of Carboplatin and Vinorelbine i.v. (Day 1) and Orally (Day 8) for Malignant Pleural Mesothelioma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose is to evaluate the activity and feasibility of a two drug regimen which is partly orally and partly intravenous in advanced pleural mesothelioma.
Detailed description
Chemotherapy with carboplatin i.v. day one in each cycle Vinorelbine i.v. day one, and orally day 8 in each cycle, repeat new cycle every 3 weeks. Total of 6 cycles. Endpoint is response rate, secondary endpoints survival and toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carboplatin and Vinorelbine |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2006-01-06
- Last updated
- 2009-09-18
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00272558. Inclusion in this directory is not an endorsement.